Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma - 08/08/17
pages | 7 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | Baicalein possesses potent anti-HCC activity both in vitro and in vivo. |
• | Baicalein exerts its anti-HCC effect via several cancer-related signaling or molecules. |
• | Baicalein may be developed as a potential, novel anti-cancer drug for HCC treatment. |
Abstract |
Baicalein (5,6,7-trihydroxy-2-phenyl-4H-1-benzopyran-4-one) is a flavonoid compound derived from the roots of Scutellaria baicalensis. It has historically been used in anti-oxidant, anti-virus, anti-bacteria, anti-inflammatory and anti-allergic therapies. Recently, baicalein has been found to possess anti-cancer activities via its effect on a variety of biological processes involving cell proliferation, metastasis, apoptosis and autophagy and so on. Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies and high fatality rate worldwide. Noteworthy, treatment protocols of HCC include conventional resection and chemotherapy, all of which may result in enormous mortality rate. Therefore, there is extreme interest to find a relatively non-toxic medicine which may reduce side effects without compromising therapeutic efficacy. Many studies have showed that baicalein is one such potential candidate. In this review, we summarized the various anti-cancer effects of baicalein on HCC and their underlying molecular mechanisms based on in vitro and in vivo experimental evidences discovered so far. Taken together, baicalein may be developed as a potential, novel anticancer drug for HCC treatment.
Le texte complet de cet article est disponible en PDF.Keywords : :Baicalein, Hepatocellular carcinoma (HCC), Anti-cancer, Mechanisms
Plan
Vol 93
P. 1285-1291 - septembre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?